According to genetic studies, mutations in the CFHR1 and CFHR5 genes are associated with kidney and eye diseases where inappropriate or excessive complement activation is implicated at the glomerular basement membrane (GBM) or at the Bruch’s membrane (BM) (3, 8, 20–28). This evidence concerns the gene CFHR5 and eye disorder.